Epidemiology of Cardiovascular Disease in Patients with Type 1 Diabetes: European Perspective

 

 Buy Article Permissions and Reprints

Abstract

The International Diabetes Federation estimated that 5.1 million people aged between 20 and 79 years died from diabetes in 2013, accounting for 8.4% of global all-cause mortality among people in this age group. Type 1 diabetes is associated with a 2- to 4-fold increased mortality risk compared with the general population. Before the onset of late complications, most of the excess mortality is from potentially preventable causes of death such as ketoacidosis, whereas the long-term excess mortality is largely due to cardiovascular disease. However, a wide geographic variation in mortality of type 1 diabetic patients has been evidenced and accurate estimates of mortality attributable to diabetes are difficult to obtain. The review provides an overview of currently available evidence and summarizes main problems in estimating early and long-term mortality by cause of death in type 1 diabetes, paying particular attention to European studies.

• References

• 1 Matsushima M, LaPorte RE, Maruyama M et al. Geographic variation in mortality among individuals with youth-onset diabetes mellitus across the world. DERI Mortality Study Group. Diabetes Epidemiology Research International. Diabetologia 1997; 40: 212-216
  CrossrefPubMedGoogle Scholar
• 2 Andersson DK, Svärdsudd K. The value of death certification statistics in measuring mortality in persons with diabetes. Scand J Prim Health Care 1994; 12: 114-120
  CrossrefPubMedGoogle Scholar
• 3 Tripathi A, Rizvi AA, Knight LM et al. Prevalence and impact of initial misclassification of pediatric type 1 diabetes mellitus. South Med J 2012; 105: 513-517
  CrossrefPubMedGoogle Scholar
• 4 Ali Z, Levine B, Ripple M et al. Diabetic ketoacidosis: a silent death. Am J Forensic Med Pathol 2012; 33: 189-193
  CrossrefPubMedGoogle Scholar
• 5 Tattersall RB, Gill GV. Unexplained deaths of type 1 diabetic patients. Diabet Med 1991; 8: 49-58
  CrossrefPubMedGoogle Scholar
• 6 Patterson CC, Dahlquist G, Harjutsalo V et al. Early mortality in EURODIAB population-based cohorts of type 1 diabetes diagnosed in childhood since 1989. Diabetologia 2007; 50: 2439-2442
  CrossrefPubMedGoogle Scholar
• 7 Secrest AM, Becker DJ, Kelsey SF et al. Characterizing sudden death and dead-in-bed syndrome in Type 1 diabetes: analysis from two childhood-onset Type 1 diabetes registries. Diabet Med 2011; 28: 293-300
  PubMedGoogle Scholar
• 8 Harjutsalo V, Maric-Bilkan C, Forsblom C et al. Impact of sex and age at onset of diabetes on mortality from ischemic heart disease in patients with type 1 diabetes. Diabetes Care 2014; 37: 144-108
  CrossrefPubMedGoogle Scholar
• 9 Dahlquist G, Källén B. Mortality in childhood-onset type 1 diabetes: a population-based study. Diabetes Care 2005; 28: 2384-2387
  CrossrefPubMedGoogle Scholar
• 10 Wibell L, Nyström L, Ostman J et al. Increased mortality in diabetes during the first 10 years of the disease. A population-based study (DISS) in Swedish adults 15-34 years old at diagnosis. J Intern Med 2001; 249: 263-270
  CrossrefPubMedGoogle Scholar
• 11 Bruno G, Cerutti F, Merletti F et al. Piedmont Study Group for Diabetes Epidemiology . Short-term mortality risk in children and young adults with type 1 diabetes: the population-based Registry of the Province of Turin, Italy. Nutr Metab Cardiovasc Dis 2009; 19: 340-344
  CrossrefPubMedGoogle Scholar
• 12 Laing SP, Swerdlow AJ, Slater SD et al. The British Diabetic Association Cohort Study, I: all-cause mortality in patients with insulin-treated diabetes mellitus. Diabet Med 1999; 16: 459-465
  CrossrefPubMedGoogle Scholar
• 13 Laing SP, Swerdlow AJ, Slater SD et al. The British Diabetic Association Cohort Study, II: cause-specific mortality in patients with insulin-treated diabetes mellitus. Diabet Med 1999; 16: 466-471
  CrossrefPubMedGoogle Scholar
• 14 Skrivarhaug T, Bangstad HJ, Stene LC et al. Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway. Diabetologia 2006; 49: 298-305
  CrossrefPubMedGoogle Scholar
• 15 Soedamah-Muthu SS, Fuller JH, Mulnier HE et al. All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992-1999. Diabetologia 2006; 49: 660-666
  CrossrefPubMedGoogle Scholar
• 16 Soedamah-Muthu SS, Fuller JH, Mulnier HE et al. High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database. Diabetes Care 2006; 29: 798-804
  CrossrefPubMedGoogle Scholar
• 17 Harjutsalo V, Forsblom C, Groop PH. Time trends in mortality in patients with type 1 diabetes: nationwide population based cohort study. BMJ 2011; 343: d5364
  CrossrefPubMedGoogle Scholar
• 18 Podar T, Solntsev A, Reunanen A et al. Mortality in patients with childhood-onset type 1 diabetes in Finland, Estonia, and Lithuania: follow-up of nationwide cohorts. Diabetes Care 2000; 23: 290-294
  CrossrefPubMedGoogle Scholar
• 19 Waernbaum I, Blohmé G, Ostman J et al. Excess mortality in incident cases of diabetes mellitus aged 15 to 34 years at diagnosis: a population-based study (DISS) in Sweden. Diabetologia 2006; 49: 653-659
  CrossrefPubMedGoogle Scholar
• 20 Allemann S, Saner C, Zwahlen M et al. Long-term cardiovascular and non-cardiovascular mortality in women and men with type 1 and type 2 diabetes mellitus: a 30-year follow-up in Switzerland. Swiss Med Wkly 2009; 139: 576-583
  PubMedGoogle Scholar
• 21 Jørgensen ME, Almdal TP, Carstensen B. Time trends in mortality rates in type 1 diabetes from 2002 to 2011. Diabetologia 2013; 56: 2401-2404
  CrossrefPubMedGoogle Scholar
• 22 Laing SP, Swerdlow AJ, Carpenter LM et al. Mortality from cerebrovascular disease in a cohort of 23 000 patients with insulin-treated diabetes. Stroke 2003; 34: 418-421
  CrossrefPubMedGoogle Scholar
• 23 Putaala J, Curtze S, Hiltunen S et al. Causes of death and predictors of 5-year mortality in young adults after first-ever ischemic stroke: the Helsinki Young Stroke Registry. Stroke 2009; 40: 2698-2703
  CrossrefPubMedGoogle Scholar
• 24 Lindsay RS, Little J, Jaap AJ et al. Diabetic nephropathy is associated with an increased familial risk of stroke. Diabetes Care 1999; 22: 422-425
  CrossrefPubMedGoogle Scholar
• 25 Rossing P, Hougaard P, Borch-Johnsen K et al. Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. BMJ 1996; 313: 779-784
  CrossrefPubMedGoogle Scholar
• 26 Rossing P, Breum L, Major-Pedersen A et al. Prolonged QTc interval predicts mortality in patients with Type 1 diabetes mellitus. Diabet Med 2001; 18: 199-205
  CrossrefPubMedGoogle Scholar
• 27 Mühlhauser I, Overmann H, Bender R et al. Predictors of mortality and end-stage diabetic complications in patients with Type 1 diabetes mellitus on intensified insulin therapy. Diabet Med 2000; 17: 727-734
  CrossrefPubMedGoogle Scholar
• 28 Forssas E, Manderbacka K, Arffman M et al. Socio-economic predictors of mortality among diabetic people. Eur J Public Health 2012; 22: 305-310
  CrossrefPubMedGoogle Scholar
• 29 Forssas EH, Keskimäki IT, Reunanen AR et al. Coronary heart disease among diabetic and nondiabetic people – socioeconomic differences in incidence, prognosis and mortality. J Diabetes Complications 2008; 22: 10-17
  CrossrefPubMedGoogle Scholar
• 30 The Diabetes Control and Complications Trial Research Group . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986
  CrossrefPubMedGoogle Scholar
• 31 Klein BE, Klein R, McBride PE et al. Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy. Arch Intern Med 2004; 164: 1917-1924
  CrossrefPubMedGoogle Scholar
• 32 Nathan DM, Cleary PA, Backlund JY et al. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005; 353: 2643-2653
  CrossrefPubMedGoogle Scholar
• 33 Prince CT, Becker DJ, Costacou T et al. Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC). Diabetologia 2007; 50: 2280-2288
  CrossrefPubMedGoogle Scholar
• 34 Soedamah-Muthu SS, Chaturvedi N, Witte DR et al. EURODIAB Prospective Complications Study Group. Relationship between risk factors and mortality in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study (PCS). Diabetes Care 2008; 31: 1360-1366
  CrossrefPubMedGoogle Scholar
• 35 Eeg-Olofsson K, Cederholm J, Nilsson PM et al. Glycemic control and cardiovascular disease in 7 454 patients with type 1 diabetes: an observational study from the Swedish National Diabetes Register (NDR). Diabetes Care 2010; 33: 1640-1646
  CrossrefPubMedGoogle Scholar
• 36 Thomas MC, Moran J, Forsblom C et al. FinnDiane Study Group . The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care 2011; 34: 861-866
  CrossrefPubMedGoogle Scholar
• 37 Orchard TJ, LLoyd CE, Maser RE et al. Why does diabetic autonomic neuropathy predict IDDM mortality? An analysis from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Res Clin Pract 1996; 34: S165-S171
  CrossrefPubMedGoogle Scholar
• 38 Astrup AS, Tarnow L, Rossing P et al. Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy. Diabetes Care 2006; 29: 334-339
  CrossrefPubMedGoogle Scholar
• 39 Forsblom C, Thomas MC, Moran J et al. FinnDiane Study Group . Serum adiponectin concentration is a positive predictor of all-cause and cardiovascular mortality in type 1 diabetes. J Intern Med 2011; 270: 346-355
  CrossrefPubMedGoogle Scholar
• 40 Furfaro AL, Sanguineti R, Storace D et al. Metalloproteinases and advanced glycation end products: coupled navigation in atherosclerotic plaque pathophysiology?. Exp Clin Endocrinol Diabetes 2012; 120: 586-590
  Article in Thieme ConnectPubMedGoogle Scholar
• 41 Skrha Jr J, Kalousová M, Svarcová J et al. Relationship of soluble RAGE and RAGE ligands HMGB1 and EN-RAGE to endothelial dysfunction in type 1 and type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 2012; 120: 277-281
  Article in Thieme ConnectPubMedGoogle Scholar
• 42 Thomas MC, Söderlund J, Lehto M et al. FinnDiane Study Group . Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes. Diabetologia 2011; 54: 2669-2677
  CrossrefPubMedGoogle Scholar
• 43 Lopes-Virella MF, Hunt KJ, Baker NL et al. VADT Investigators . The levels of MDA-LDL in circulating immune complexes predict myocardial infarction in the VADT study. Atherosclerosis 2012; 224: 526-531
  CrossrefPubMedGoogle Scholar
• 44 Astrup AS. Cardiovascular morbidity and mortality in diabetes mellitus: prediction and prognosis. Dan Med Bull 2011; 58: B4152
  PubMedGoogle Scholar
• 45 Chen YH, Feng B, Chen ZW. Statins for primary prevention of cardiovascular and cerebrovascular events in diabetic patients without established cardiovascular diseases: a meta-analysis. Exp Clin Endocrinol Diabetes 2012; 120: 116-120
  Article in Thieme ConnectPubMedGoogle Scholar
• 46 Song JW, Chung KC. Observational studies: cohort and case-control studies. Plast Reconstr Surg 2010; 126: 2234-2242
  CrossrefPubMedGoogle Scholar
• 47 Roglic G, Unwin N, Bennett PH et al. The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care 2005; 28: 2130-2135
  CrossrefPubMedGoogle Scholar
• 48 Boyko EJ. Progress in the estimation of mortality due to diabetes. Diabetes Care 2005; 28: 2320-2321
  CrossrefPubMedGoogle Scholar
• 49 von Elm E, Altman DG, Egger M et al. STROBE Initiative . The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370: 1453-1457
  CrossrefPubMedGoogle Scholar
• 50 McEwen LN, Kim C, Haan M et al. TRIAD Study Group . Diabetes reporting as a cause of death: results from the Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care 2006; 29: 247-253
  CrossrefPubMedGoogle Scholar
• 51 Hassan Sadek N, Sadek AR, Tahir A et al. Evaluating tools to support a new practical classification of diabetes: excellent control may represent misdiagnosis and omission from disease registers is associated with worse control. Int J Clin Pract 2012; 66: 874-882
  CrossrefPubMedGoogle Scholar